Thymic neuroendocrine tumour (carcinoid): Clinicopathological features of four patients with different presentation

Interactive Cardiovascular and Thoracic Surgery

Volumn 11, Issue 6, 2010, Pages 732-736

  Dutta, Roman ^a   Kumar, Arvind ^a   Julka, Pramod Kumar ^a   Mathur, Sandeep Rajinder ^a   Kaushal, Seema ^a   Kumar, Rakesh ^a   Jindal, Tarun ^a   Suri, Vaishali ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

68 DOTATOC PET CT; Cushing's syndrome; Neuroendocrine tumour; Thymic carcinoid

Indexed keywords

CHROMOGRANIN A; CORTICOTROPIN; DEXAMETHASONE; GADOTERIC ACID; GALLIUM 68; HYDROCORTISONE; NEURON SPECIFIC ENOLASE; OCTREOTIDE; PROLACTIN; STEM CELL FACTOR RECEPTOR; SYNAPTOPHYSIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; BONE SCINTISCANNING; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW BACK PAIN; LUMBAR VERTEBRA; MALE; MITOSIS; NEUROENDOCRINE TUMOR; OBESITY; PARAPLEGIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPINAL CORD METASTASIS; SURVIVAL TIME; THYMUS; TUMOR VOLUME;

ADULT; BIOPSY; CARCINOID TUMOR; CHEMOTHERAPY, ADJUVANT; CUSHING SYNDROME; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INDIA; LUMBAR VERTEBRAE; MALE; NEOPLASM STAGING; OCTREOTIDE; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SPINAL NEOPLASMS; THYMECTOMY; THYMUS NEOPLASMS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78649612713     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2010.237651     Document Type: Article

References (14)

1. Rosai J, Higa E, Davie J. Mediastinal endocrine neoplasm in patients with multiple endocrine adenomatosis: a previously unrecognized association. Cancer 1972;29:1075-1083.
2. Gal AA, Kornstein MJ, Cohen C, Duarte IG, Miller JI, Mansour KA. Neuroendocrine tumors of the thymus: a clinicopathological and prognostic study. Ann Thorac Surg 2001;72:1179-1182.
3. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2003;88:5593-5602.
4. Isidori AM, Kaltsas GA, Pozza C, Frajese V, Newell-Price J, Reznek RH, Jenkins PJ, Monson JP, Grossman AB, Besser GM. The ectopic adreno-corticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 2006;91:371-377.
5. Doppman JL, Oldfield EH, Nieman LK. Bilateral sampling of the internal jugular vein to distinguish between mechanisms of adrenocorticotropic hormone-dependent Cushing syndrome. Ann Intern Med 1998;128:33-36.
6. Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, van Hagen M, Postema PT, de Jong M, Reubi JC. Somatostatin receptor scintigraphy with (111In-DTPA-D-Phe1) and (123I-Tyr3)-octreo-tide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-731.
7. Leondi A, Koutsikos J, Zerva C. Interpretation of the post-surgical somatostatin receptor scintigram of a primary neuroendocrine tumor of the thymus: a case report and literature review. Int Semin Surg Oncol 2005;2:7.
8. Tiffet O, Nicholson AG, Ladas G, Sheppard MN, Goldstraw P. A clinico-pathologic study of 12 neuroendocrine tumors arising in the thymus. Chest 2004;125:2368-2369.
9. Hofmann M, Maecke H, Borner R, Weckesser E, Schoffski P, Oei L, Schumacher J, Henze M, Heppeler A, Meyer J, Knapp H. Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. Eur J Nucl Med 2001;28:1751-1757.
10. Koukouraki S, Strauss LG, Georgoulias V, Eisenhut M, Haberkorn U, Dimitrakopoulou-Strauss A. Comparison of the pharmacokinetics of 68Ga-DOTATOC and w18Fx FDG in patients with metastatic neuroendo-crine tumors scheduled for 90Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging 2006;33:1115-1122.
11. Moran CA, Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol 2000;114:100-110.
12. Fukai I, Masaoka A, Fujii Y, Yamakawa Y, Yokoyama T, Murase T, Eimoto T. Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients. Ann Thorac Surg 1999;67:208-211.
13. Dham A, Truskinovsky AM, Dudek AZ. Thymic carcinoid responds to neoadjuvant therapy with sunitinib and octreotide: a case report. J Thorac Oncol 2008;3:94-97.
14. Dosios T, Nikou GC, Toubanakis C, Filippides T, Papachristou D. Multi-modality treatment of neuroendocrine tumors of the thymus. Thorac Cardiovasc Surg 2005;53:305-309.